Up to 60% off Profit Pro - Limited Time Offer!
Winter Sale
60% off Profit Pro - Limited Time Offer!
Aligos Therapeutics Inc
ALGS · NASDAQ41.13
41.13
USD1.864.74%
Get Full Access with Profit PRO
Unlock the complete financials of this stock
Balance Sheet
Total Assets
107.73M
146.52M
265.3M
Liabilities And Stockholders Equity
107.73M
146.52M
265.3M
Income Statement
Total Revenue
-
-
-10.55M
Cost Of Revenue
1.29M
2.3M
3.33M
Gross Profit
-1.29M
-2.3M
-10.55M
Total Operating Expenses
13.66M
54.04M
97.83M
Operating Income
-13.66M
-54.04M
-97.83M
Income Before Tax
-13.93M
-52.18M
-108.38M
Net Income After Taxes
-13.93M
-52.26M
-108.54M
Net Income Before Extraordinary Items
-13.93M
-52.26M
-108.54M
Net Income
-13.93M
-52.26M
-108.54M
Net Income Applicable To Common Shares
-15.2M
-52.26M
-108.54M
Diluted Net Income
-15.2M
-52.26M
-108.54M
Diluted Weighted Average Shares
21.17
21.93
31.47
Diluted EPS Excluding Extraordinary Items
-0.66
-2.38
-3.45
Diluted Normalized EPS
-0.72
-2.38
-3.45
EBIT
-13.66M
-54.04M
-97.83M
Cash Flow
Total Cash From Operating Activities
-6.05M
-46.77M
-74.26M
Total Cash Flows From Investing Activities
-75.59M
6.79M
32.76M
Total Cash From Financing Activities
99.89M
85.53M
192.35M
Exchange Rate Changes
-
-
-
Change In Cash
24.55M
45.56M
150.84M
Free Cash Flow
-8.56M
-49.55M
-76.33M
What are you waiting for?Start making profit today
©
2024
All rights reserved